Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study Investigating How Effective Secondary Prevention Patients Are Treated to Their LDL-C Targets

NCT00536965 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00536965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00536965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study Investigating How Effective Secondary Prevention Patients Are Treated to Their LDL-C Targets
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2007
Completion date
December 31, 2007
Enrollment
951 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, carotid stenosis, coronary heart disease, diabetes mellitus, hyperlipidemias, peripheral vascular diseases